首页 | 本学科首页   官方微博 | 高级检索  
     


Low RAI2 expression is a marker of poor prognosis in breast cancer
Authors:Nishikawa  Sayaka  Uemoto  Yasuaki  Kim  Tae-Sun  Hisada   Tomoka  Kondo   Naoto  Wanifuchi-Endo  Yumi  Fujita  Takashi  Asano  Tomoko  Katagiri  Yusuke  Terada  Mitsuo  Kato  Akiko  Dong  Yu  Sugiura  Hiroshi  Okuda  Katsuhiro  Kato  Hiroyuki  Osaga  Satoshi  Takahashi  Satoru  Toyama  Tatsuya
Affiliation:1.Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan
;2.Advanced Medicine, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 647-8601, Japan
;3.Department of Oncology, Immunology and Surgery, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan
;4.Department of Experimental Pathology and Tumor Biology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan
;5.Clinical Research Management Center, Nagoya City University Hospital, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya, 467-8601, Japan
;6.Department of Breast and Endocrine Surgery, Toyokawa City Hospital, 23 Noji, Yawata-cho, Toyokawa, 442-8561, Japan
;
Abstract:Breast Cancer Research and Treatment - Retinoic acid-induced 2 (RAI2) has been shown to be a putative suppressor of the early hematogenous dissemination of tumor cells to the bone marrow in breast...
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号